History

 

Eskayef Bangladesh Limited, a successor of world-renowned multinational pharmaceutical company, SmithKline & French (SK&F), USA was acquired by TRANSCOM in 1990 in the wake of the merger between SmithKline & French, USA and Beecham, UK. TRANSCOM is one of the leading and fastest growing business conglomerates in Bangladesh. Like TRANSCOM, not many industrial groups in Bangladesh can claim a history of continuous business pursuits stretching back over 100 years. Over the time, its early industrial ventures have moved over to businesses involved in high-tech manufacturing, international trading and distribution, forming strong ties with a host of blue chip multinational companies.

After the acquisition of SK&F by TRANSCOM, the new company was named – Eskayef Bangladesh Limited and it has subsequently culminated to become one of the leading pharmaceutical companies of Bangladesh. Rapid business growth since its inception have propelled Eskayef to a position of eminence among the pharmaceutical companies operating in Bangladesh today.

Eskayef's Landmarks

1979

Incorporation as a subsidiary of SmithKline & French, USA

1999

Introduction of Pellet Technology in Bangladesh

2001

Commencement of Animal Health & Nutrition Division

2008

Achivement of UK MHRA accreditation
Initiation of Cepha Plant

2010

Attainment of TGA Australia accreditation

2013

Accomplishment of EU GMP accreditation and Launching of Eye Care Project

1990

Acquisition of Smithkline & French (SK&F), USA by Transcom

2001

Acquition of old Squibb plant at Tongi by Transcom Group

2006

Inception of state of the art Tongi plant

2010

Starting af Novo Nordisk's Insulin Manufacturing

2011

Obtention of VMD UK accreditation

2014

Achievement of UAE GMP accreditation